Publication | Closed Access

Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway

Diabetic RetinopathyOcular DiseaseSignal TransductionOphthalmologyMedicineDiabetesDiabetes-induced Proliferative RetinopathyDiabetes MellitusGambogic AcidPharmacologyCell BiologyCell SignalingPi3k/akt Pathway